This report analyzes the expanding veterinary orthopedics market, driven by a rising incidence of musculoskeletal disorders in companion and livestock animals. Key growth drivers include technological advancements in biomaterials, 3D-printed surgical guides, and increased pet owner spending on specialized care. While veterinary hospitals and clinics currently dominate the end-user segment, the companion animal market is projected to experience significant growth. Furthermore, the Asia Pacific region is expected to witness the fastest expansion due to improving veterinary infrastructure.

Market Overview

The veterinary orthopedics market is projected to grow from USD 0.57 billion in 2026 to USD 0.86 billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.5%. This growth is driven by several key factors shaping the future of veterinary orthopedic care, surgical intervention, and mobility restoration in animals.


Market Drivers and Trends

Key Growth Drivers

• Rising Incidence of Disorders: Increasing cases of musculoskeletal disorders, trauma, and degenerative joint diseases in both companion and livestock animals.
• Pet Owner Behavior: Growing willingness among pet owners to opt for advanced orthopedic procedures.
• Specialization in Veterinary Care: A steady evolution toward greater specialization and results-oriented care, driving demand for superior orthopedic implants, fixation devices, and procedure-oriented surgical solutions.
• Demand for Innovation: Veterinary hospitals and specialty practices are actively seeking innovative solutions to improve surgical accuracy, recovery time, and post-surgical mobility.
• Demographic and Health Factors: Increasing prevalence of age-related orthopedic diseases, joint diseases in obese patients, and trauma-related cases necessitating effective, reliable, and standardized orthopedic procedures.
• Specialized Services: Increased referrals and the rise of specialized orthopedic practices.
• Modernization Trends: Advancements in imaging, digital surgical planning, and post-operative rehabilitative care.
• Professional Development: A growing emphasis on surgeon education and evidence-based best practices.

Technological Advancements

• Enhanced Biomaterials: Development of improved materials for orthopedic use.
• Patient-Specific Solutions: Use of patient-specific devices and 3D-printed surgical guides.
• Minimally Invasive Procedures: Adoption of less invasive surgical techniques.
• Device Usability: Enhancements in the quality and ease of usage of devices are expected to contribute to market growth during the forecasted period.

Market Segmentation

By Animal Type

• Companion Animals: This segment is projected to grow at the highest CAGR during the forecast period. Dogs and cats are particularly prone to orthopedic disorders such as ligament tears, fractures, and joint disorders due to aging or obesity, creating constant demand. Growth is further supported by:
• Easy accessibility of specialty animal hospitals.
• Growing awareness among owners regarding procedure outcomes.
• Gradually increasing adoption rates of pet insurance plans.

By End User

• Veterinary Hospitals & Clinics: This segment accounted for the largest market share in 2025. They serve as primary locations for diagnosis, surgery, and post-surgical follow-up. Growth is driven by:
• High volume of trauma cases, ligament injuries, and degenerative joint disorders.
• Increasing presence of highly sophisticated surgical facilities and orthopedic capabilities.
• Development of multi-specialty veterinary hospitals and the shift toward in-house orthopedic care rather than referral-based care.

By Region

• Asia Pacific: Expected to witness the highest growth rate during the forecast period. Growth factors include:
• Accelerated growth in the number of pet owners.
• Continued increases in expenditure on animal care in countries such as China, India, Japan, and Australia.
• Improvement in veterinary infrastructure, including the development of orthopedic specialty hospitals and referral centers.
• Increased access to diagnostic work-ups and surgeries.
• Growing recognition of the role of mobility in quality of life.
• Increased availability of orthopedic surgeons and pet insurance.

Interview Breakdown

Supply-Side Primary Interviews

• By Company Type:
• Tier 1: 60%
• Tier 2: 30%
• Tier 3: 10%
• By Designation:
• C-level Executives: 30%
• Directors: 50%
• Other Designations: 20%
• By Region:
• North America: 40%
• Europe: 25%
• Asia Pacific: 20%
• Latin America: 10%
• Middle East & Africa: 5%

Demand-Side Primary Interviews

• By End User:
• Veterinary Hospitals & Clinics: 45%
• Specialty Orthopedic Clinics: 24%
• Emergency Animal Hospitals: 14%
• Academic & Research Institutes: 10%
• Animal Rehabilitation Centers: 7%
• By Designation:
• Veterinarians: 47%
• Veterinary Hospital Directors & Managers: 22%
• Veterinary Critical Care Specialists: 15%
• Others: 16%
• By Region:
• North America: 25%
• Europe: 24%
• Asia Pacific: 25%
• Latin America: 11%
• Middle East & Africa: 15%

Research Coverage

The market study covers the veterinary orthopedics market across various segments, aiming to estimate market size and growth potential by:

• Product
• Material
• Animal Type
• Application
• End User
• Region

Additionally, the study includes an in-depth competitive analysis of key players, featuring company profiles, key observations on products and business offerings, recent developments, and key market strategies.

Strategic Value: Reasons to Buy the Report

This report assists both established companies and newer or smaller firms in understanding market trends to capture larger market shares. Firms can implement strategies based on the following insights:

• Comprehensive Market Analysis:
• Drivers: Rising companion animal ownership/spending, higher incidence of orthopedic conditions, growth in specialty hospitals/referral networks, and technological improvements in implants/instruments.
• Restraints: High cost of orthopedic implants, instruments, and advanced surgical procedures; limited availability of trained veterinary orthopedic surgeons.
• Opportunities: Geographic expansion into emerging markets and growing adoption of patient-specific implants and 3D-printed guides.
• Challenges: Clinical outcome variability, complication risks, and regulatory/quality compliance across different regions.
• Product Development/Innovation: Detailed insights into upcoming technologies and product launches.
• Market Development: Comprehensive information regarding lucrative emerging markets and analysis of various veterinary orthopedic product types across regions.
• Market Diversification: Exhaustive information regarding products, untapped regions, recent developments, and investments.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players.

• 1 INTRODUCTION 50

  • 1.1 STUDY OBJECTIVES 50

  • 1.2 MARKET DEFINITION 50

  • 1.3 STUDY SCOPE 50

    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 51

    • 1.3.2 INCLUSIONS & EXCLUSIONS 52

    • 1.3.3 YEARS CONSIDERED 53

  • 1.4 MARKET STAKEHOLDERS 53

• 2 EXECUTIVE SUMMARY 55

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 55

  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 56

  • 2.3 DISRUPTIVE TRENDS IN VETERINARY ORTHOPEDICS MARKET 57

  • 2.4 HIGH-GROWTH SEGMENTS 58

  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 59

• 3 PREMIUM INSIGHTS 60

  • 3.1 VETERINARY ORTHOPEDICS MARKET OVERVIEW 60

  • 3.2 ASIA PACIFIC: VETERINARY ORTHOPEDICS MARKET, BY PRODUCT & COUNTRY (2025) 61

  • 3.3 VETERINARY ORTHOPEDICS MARKET: REGIONAL MIX 62

  • 3.4 VETERINARY ORTHOPEDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62

  • 3.5 VETERINARY ORTHOPEDICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 63

• 4 MARKET OVERVIEW 64

  • 4.1 INTRODUCTION 64

  • 4.2 MARKET DYNAMICS 64

    • 4.2.1 DRIVERS 65

      • 4.2.1.1 Rising companion animal ownership and spending on pet healthcare 65
      • 4.2.1.2 Higher incidence of orthopedic conditions 66
      • 4.2.1.3 Growth in specialty veterinary hospitals & referral networks with advanced surgical capabilities 67
      • 4.2.1.4 Technology improvements in implants and instruments 67

    • 4.2.2 RESTRAINTS 68

      • 4.2.2.1 High cost of orthopedic implants, instruments, and advanced surgical procedures 68
      • 4.2.2.2 Limited availability of trained veterinary orthopedic surgeons 69

    • 4.2.3 OPPORTUNITIES 69

      • 4.2.3.1 Geographic expansion into emerging markets 69
      • 4.2.3.2 Growing adoption of patient-specific implants and 3D-printed guides 70

    • 4.2.4 CHALLENGES 71

      • 4.2.4.1 Clinical outcome variability and complication risk 71
      • 4.2.4.2 Regulatory and quality compliance across regions 71

  • 4.3 UNMET NEEDS & WHITE SPACES 72

    • 4.3.1 UNMET NEEDS IN VETERINARY ORTHOPEDICS MARKET 72

    • 4.3.2 WHITE SPACE OPPORTUNITIES 73

  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 73

    • 4.4.1 INTERCONNECTED MARKETS 73

    • 4.4.2 CROSS-SECTOR OPPORTUNITIES 74

  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 75

    • 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 75

• 5 INDUSTRY TRENDS 76

  • 5.1 PORTER’S FIVE FORCES ANALYSIS 76

    • 5.1.1 THREAT OF NEW ENTRANTS 77

    • 5.1.2 THREAT OF SUBSTITUTES 78

    • 5.1.3 BARGAINING POWER OF SUPPLIERS 78

    • 5.1.4 BARGAINING POWER OF BUYERS 78

    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 79

  • 5.2 MACROECONOMIC INDICATORS 79

    • 5.2.1 INTRODUCTION 79

    • 5.2.2 GDP TRENDS & FORECAST 79

    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 81

    • 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 81

  • 5.3 SUPPLY CHAIN ANALYSIS 81

  • 5.4 VALUE CHAIN ANALYSIS 83

  • 5.5 ECOSYSTEM ANALYSIS 84

  • 5.6 PRICING ANALYSIS 85

    • 5.6.1 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC PRODUCTS, BY KEY PLAYER, 2023-2025 86

      • 5.6.1.1 Average selling price trend of veterinary orthopedic plates
      • 5.6.1.2 Average selling price trend of veterinary orthopedic screws
      • 5.6.1.3 Average selling price trend of veterinary orthopedic instruments
      • 5.6.1.4 Average selling price trend of veterinary orthopedic consumables

    • 5.6.2 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC PRODUCTS, BY MATERIAL TYPE, 2023-2025 88

      • 5.6.2.1 Average selling price trend of metallic veterinary orthopedic products, by type, 2023-2025 88
      • 5.6.2.2 Average selling price trend of absorbable veterinary orthopedic products, by type, 2023-2025 88

    • 5.6.3 AVERAGE SELLING PRICE TREND OF VETERINARY ORTHOPEDIC

      • 5.6.3.1 Average selling price trend of compression plates
      • 5.6.3.2 Average selling price trend of locking plates, by region, 2023-2025 89
      • 5.6.3.3 Average selling price trend of locking screws, by region, 2023-2025 89
      • 5.6.3.4 Average selling price trend of drilling systems, by region, 2023-2025 90
      • 5.6.3.5 Average selling price trend of cutting tools, by region, 2023-2025 90

  • 5.7 TRADE ANALYSIS 90

    • 5.7.1 TRADE DATA FOR HS CODE 9021 91

      • 5.7.1.1 Import data for HS Code 9021 91
      • 5.7.1.2 Export data for HS Code 9021 91

    • 5.7.2 TRADE DATA FOR HS CODE 9018 92

      • 5.7.2.1 Import data for HS Code 9018 92
      • 5.7.2.2 Export data for HS Code 9018 92

  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027 93

  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94

  • 5.10 INVESTMENT & FUNDING SCENARIO 95

  • 5.11 SUCCESS STORIES & REAL-WORLD APPLICATIONS 96

    • 5.11.1 PATIENT-SPECIFIC 3D-PRINTED IMPLANTS FOR COMPLEX CANINE

    • 5.11.2 ADVANCED FRACTURE FIXATION IN SMALL ANIMALS USING MODERN ORTHOPEDIC IMPLANT SYSTEMS 96

    • 5.11.3 LONG-TERM CLINICAL OUTCOMES OF ADVANCED ORTHOPEDIC SURGICAL INTERVENTIONS IN COMPANION ANIMALS 97

  • 5.12 IMPACT OF 2025 US TARIFFS ON VETERINARY ORTHOPEDICS MARKET 97

    • 5.12.1 INTRODUCTION 97

    • 5.12.2 KEY TARIFF RATES 98

    • 5.12.3 PRICE IMPACT ANALYSIS 99

    • 5.12.4 IMPACT ON COUNTRY/REGION 100

      • 5.12.4.1 North America 100
      • 5.12.4.2 Asia Pacific 100
      • 5.12.4.3 Europe 101
      • 5.12.4.4 Latin America 102

    • 5.12.5 IMPACT ON END-USE INDUSTRIES 102

      • 5.12.5.1 Veterinary hospitals & clinics 102
      • 5.12.5.2 Specialty orthopedic clinics 102
      • 5.12.5.3 Emergency animal hospitals 102
      • 5.12.5.4 Academic & research institutes 103
      • 5.12.5.5 Animal rehabilitation centers 103

• 6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS

  • 6.1 TECHNOLOGY ANALYSIS 104

    • 6.1.1 KEY EMERGING TECHNOLOGIES 104

      • 6.1.1.1 Patient-specific 3D printing 104
      • 6.1.1.2 Minimally invasive orthopedic techniques 104
      • 6.1.1.3 Bioresorbable/Biodegradable implants 105

    • 6.1.2 COMPLEMENTARY TECHNOLOGIES 105

      • 6.1.2.1 C-arm/Fluoroscopy & cone-beam CT units 105
      • 6.1.2.2 On-site bone printing/Bone glue-gun approaches 106

    • 6.1.3 ADJACENT TECHNOLOGIES 106

      • 6.1.3.1 Small animal prosthetics and orthoses 106
      • 6.1.3.2 Implant surface engineering and coatings 107

  • 6.2 TECHNOLOGY/PRODUCT ROADMAP 107

    • 6.2.1 NEAR TERM (2025-2027) 107

    • 6.2.2 MID TERM (2028-2030) 108

    • 6.2.3 LONG TERM (2030+) 108

  • 6.3 PATENT ANALYSIS 108

    • 6.3.1 PATENT PUBLICATION TRENDS FOR VETERINARY ORTHOPEDICS 108

    • 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 109

  • 6.4 FUTURE APPLICATIONS 111

    • 6.4.1 PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS AND SURGICAL GUIDES 111

    • 6.4.2 MINIMALLY INVASIVE AND IMAGE-GUIDED ORTHOPEDIC SURGERY 111

    • 6.4.3 REGENERATIVE AND BIOLOGICS-ENHANCED ORTHOPEDIC THERAPIES 112

    • 6.4.4 DIGITAL SURGICAL PLANNING AND AI-ASSISTED DECISION SUPPORT 112

    • 6.4.5 INTEGRATED REHABILITATION, MOBILITY TRACKING, AND LONG-TERM OUTCOME MANAGEMENT 112

  • 6.5 IMPACT OF AI/GENERATIVE AI ON VETERINARY ORTHOPEDICS MARKET 112

    • 6.5.1 INTRODUCTION 112

    • 6.5.2 MARKET POTENTIAL IN VETERINARY ORTHOPEDICS ECOSYSTEM 113

    • 6.5.3 AI USE CASES 113

    • 6.5.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY ORTHOPEDICS MARKET 114

• 7 SUSTAINABILITY & REGULATORY LANDSCAPE 115

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE 115

    • 7.1.1 REGULATORY ANALYSIS 115

    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES

    • 7.1.3 INDUSTRY STANDARDS 117

  • 7.2 SUSTAINABILITY INITIATIVES 118

    • 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY

    • 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 118

    • 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 119

• 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 120

  • 8.1 KEY STAKEHOLDERS & BUYING CRITERIA 120

    • 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 120

    • 8.1.2 BUYING CRITERIA 121

  • 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 122

    • 8.2.1 DECISION-MAKING PROCESS 122

    • 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 123

    • 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 123

    • 8.2.4 MARKET PROFITABILITY 124

• 9 VETERINARY ORTHOPEDICS MARKET, BY PRODUCT 125

  • 9.1 INTRODUCTION 126

  • 9.2 IMPLANTS 128

    • 9.2.1 PLATES 132

      • 9.2.1.1 Global volume analysis of plates, 2024-2031 (thousand units) 136
      • 9.2.1.2 Compression plates 136
        • 9.2.1.2.1 Continued preference for absolute stability in simple fractures to drive steady demand for compression plates 136
      • 9.2.1.3 Locking plates 139
        • 9.2.1.3.1 Growing cases of biologically challenged fractures and osteotomies to propel locking plate adoption 139
      • 9.2.1.4 T-plates 141
        • 9.2.1.4.1 Procedure-critical role of T-plates in distal limb fractures to maintain high adoption rates 141
      • 9.2.1.5 L-plates 143
        • 9.2.1.5.1 Growing need for stable corner and juxta-articular fixation to support L-plate adoption 143
      • 9.2.1.6 Other plates 145

    • 9.2.2 SCREWS 146

      • 9.2.2.1 Global volume analysis of screws, 2024-2031 (thousand units) 150
      • 9.2.2.2 Locking screws 150
        • 9.2.2.2.1 Locking screws to gain structural preference as absolute stability becomes critical in complex fractures 150
      • 9.2.2.3 Cortical screws 153
        • 9.2.2.3.1 Broad clinical utility and low unit cost to boost market 153

    • 9.2.3 PINS, WIRES, AND NAILS 155

      • 9.2.3.1 Simple fracture prevalence and cost efficiency to anchor demand for pins, wires, and nails 155
      • 9.2.3.2 Global volume analysis of pins, wires, and nails, 2024-2031 (thousand units) 157

    • 9.2.4 EXTERNAL FIXATORS 157

      • 9.2.4.1 Complex, high-risk fracture management to sustain demand for external fixators 157
      • 9.2.4.2 Global volume analysis of external fixators, 2024-2031

  • 9.3 INSTRUMENTS 160

    • 9.3.1 DRILLING SYSTEMS 164

      • 9.3.1.1 Complex, high-risk orthopedic procedures to sustain demand for advanced drilling systems 164

    • 9.3.2 CUTTING TOOLS 166

      • 9.3.2.1 Complex orthopedic reconstructions to drive demand for precision cutting instruments 166

    • 9.3.3 SURGICAL POWER TOOLS 168

      • 9.3.3.1 Rising demand for precision, efficiency, and high-throughput orthopedic procedures to drive adoption of surgical power tools 168

    • 9.3.4 ARTHROSCOPY EQUIPMENT 170

      • 9.3.4.1 Rising adoption of minimally invasive joint diagnosis and treatment to drive demand for arthroscopy equipment 170

  • 9.4 CONSUMABLES 173

    • 9.4.1 SUTURES 176

      • 9.4.1.1 Increasing orthopedic surgical volumes and demand for high-performance wound closure to drive growth of veterinary sutures 176
      • 9.4.1.2 Global volume analysis of sutures, 2024-2031 (thousand units) 179

    • 9.4.2 BONE GRAFT MATERIALS 179

      • 9.4.2.1 Increasing need for bone regeneration and defect reconstruction to drive demand for veterinary bone graft materials 179
      • 9.4.2.2 Global volume analysis of bone graft materials, 2024-2031 (thousand units) 182

    • 9.4.3 ORTHOBIOLOGICS 182

      • 9.4.3.1 Rising adoption of regenerative and minimally invasive therapies to drive demand for veterinary orthobiologics 182
      • 9.4.3.2 Global volume analysis of orthobiologics, 2024-2031

• 10 VETERINARY ORTHOPEDICS MARKET, BY MATERIAL 186

  • 10.1 INTRODUCTION 187

  • 10.2 METALLIC 187

    • 10.2.1 GLOBAL VOLUME ANALYSIS OF METALLIC IMPLANTS

    • 10.2.2 TITANIUM 191

      • 10.2.2.1 Superior biocompatibility and load-bearing performance to drive adoption of titanium implants in veterinary orthopedics 191

    • 10.2.3 STAINLESS STEEL 194

      • 10.2.3.1 Cost-effective strength and structural reliability to sustain demand for stainless steel implants in veterinary orthopedics 194

  • 10.3 ABSORBABLE 197

    • 10.3.1 GLOBAL VOLUME ANALYSIS OF ABSORBABLE IMPLANTS

    • 10.3.2 POLYMER 200

      • 10.3.2.1 Preference for gradual load transfer and reduced need for secondary surgery supporting polymer-based implants 200

    • 10.3.3 MAGNESIUM 203

      • 10.3.3.1 Advancements in biodegradable magnesium alloys to support adoption in veterinary orthopedic fixation 203

    • 10.3.4 COMPOSITE BIOABSORBABLE MATERIALS 205

      • 10.3.4.1 Demand for enhanced mechanical strength with biological osteoconductivity to drive adoption of composite

• 11 VETERINARY ORTHOPEDICS MARKET, BY ANIMAL TYPE 207

  • 11.1 INTRODUCTION 208

  • 11.2 COMPANION ANIMALS 209

    • 11.2.1 DOGS 212

      • 11.2.1.1 High incidence of stifle joint disorders and advanced surgical adoption to drive demand for canine orthopedic implants 212

    • 11.2.2 CATS 214

      • 11.2.2.1 Routine surgical fixation of feline fractures and miniaturized implant innovation to support market growth 214

    • 11.2.3 HORSES 216

      • 11.2.3.1 High lameness burden and arthroscopy-led precision surgery to drive demand for equine orthopedic systems 216

    • 11.2.4 OTHER COMPANION ANIMALS 218

  • 11.3 LIVESTOCK ANIMALS 220

    • 11.3.1 CATTLE 223

      • 11.3.1.1 High lameness prevalence and field-based fracture management needs to drive demand for large-animal orthopedic fixation systems 223

    • 11.3.2 PIGS 225

      • 11.3.2.1 Lameness-driven productivity to support orthopedic intervention in swine 225

    • 11.3.3 POULTRY 227

      • 11.3.3.1 High prevalence of growth-related skeletal disorders and welfare-driven intervention in high-value birds to drive demand 227

    • 11.3.4 OTHER LIVESTOCK ANIMALS 229

• 12 VETERINARY ORTHOPEDICS MARKET, BY APPLICATION 231

  • 12.1 INTRODUCTION 232

  • 12.2 JOINT REPLACEMENT 232

    • 12.2.1 TOTAL HIP REPLACEMENT 235

      • 12.2.1.1 Advancements in implant technology and surgical techniques to drive growth in total hip replacement 235

    • 12.2.2 TOTAL KNEE REPLACEMENT 237

      • 12.2.2.1 Enhanced functional outcomes and reduced recovery time to fuel demand for total knee replacement in veterinary orthopedics 237

    • 12.2.3 TOTAL ELBOW REPLACEMENT 239

      • 12.2.3.1 Innovative prosthetics and improved surgical approaches

  • 12.3 TRAUMA FIXATION 241

    • 12.3.1 FRACTURE REPAIR 244

      • 12.3.1.1 Technological advancements in fracture repair materials and methods to enhance healing times and patient recovery 244

    • 12.3.2 LIGAMENT RECONSTRUCTION 246

      • 12.3.2.1 Minimally invasive techniques and advanced materials to accelerate ligament reconstruction procedures 246

    • 12.3.3 BONE DEFORMITY CORRECTION 248

      • 12.3.3.1 Emerging surgical techniques and advanced implants to

  • 12.4 SPECIFIC PROCEDURES 250

    • 12.4.1 TIBIAL PLATEAU LEVELING OSTEOTOMY (TPLO) 253

      • 12.4.1.1 Reduced recovery time and improved post-operative mobility

    • 12.4.2 TIBIAL TUBEROSITY ADVANCEMENT (TTA) 255

      • 12.4.2.1 Increased success rates and reduced complication rates

    • 12.4.3 EXTRACAPSULAR CCL REPAIR 257

      • 12.4.3.1 Cost-effective solutions with reliable outcomes to fuel market growth 257

    • 12.4.4 ARTHROSCOPY 259

      • 12.4.4.1 Minimally invasive techniques and faster recovery times

• 13 VETERINARY ORTHOPEDICS MARKET, BY END USER 261

  • 13.1 INTRODUCTION 262

  • 13.2 VETERINARY HOSPITALS & CLINICS 262

    • 13.2.1 EXPANDING ORTHOPEDIC PROCEDURE VOLUMES IN VETERINARY HOSPITALS & CLINICS TO DRIVE IMPLANT ADOPTION 262

  • 13.3 SPECIALTY ORTHOPEDIC CLINICS 265

    • 13.3.1 RISING REFERRAL COMPLEXITY AT SPECIALTY ORTHOPEDIC CLINICS TO ACCELERATE USE OF ADVANCED FIXATION SYSTEMS 265

  • 13.4 EMERGENCY ANIMAL HOSPITALS 267

    • 13.4.1 INCREASING TRAUMA CASELOADS IN EMERGENCY ANIMAL HOSPITALS TO BOOST DEMAND FOR RAPID STABILIZATION SOLUTIONS 267

  • 13.5 ACADEMIC & RESEARCH INSTITUTES 269

    • 13.5.1 ACADEMIC & RESEARCH INSTITUTES TO ADVANCE ORTHOPEDIC INNOVATION THROUGH CLINICAL TRAINING AND VALIDATION 269

  • 13.6 ANIMAL REHABILITATION CENTERS 271

    • 13.6.1 GROWING INTEGRATION OF ANIMAL REHABILITATION CENTERS TO STRENGTHEN LONG-TERM ORTHOPEDIC CARE PATHWAYS 271

• 14 VETERINARY ORTHOPEDICS MARKET, BY REGION 273

  • 14.1 INTRODUCTION 274

  • 14.2 GLOBAL VOLUME ANALYSIS FOR VETERINARY ORTHOPEDICS MARKET, 2024-2031 275

  • 14.3 NORTH AMERICA 276

    • 14.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 277

    • 14.3.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT

    • 14.3.3 NORTH AMERICA: VOLUME ANALYSIS, BY MATERIAL

    • 14.3.4 US 286

      • 14.3.4.1 Rising pet population to drive demand for veterinary

    • 14.3.5 CANADA 293

      • 14.3.5.1 Rising pet adoption rate to drive market 293

  • 14.4 EUROPE 300

    • 14.4.1 MACROECONOMIC OUTLOOK FOR EUROPE 301

    • 14.4.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024-2031 (THOUSAND UNITS) 301

    • 14.4.3 EUROPE: VOLUME ANALYSIS, BY MATERIAL, 2024-2031 (THOUSAND UNITS) 302

    • 14.4.4 GERMANY 309

      • 14.4.4.1 Germany to dominate European market 309

    • 14.4.5 UK 316

      • 14.4.5.1 Increasing pet ownership to drive market growth 316

    • 14.4.6 FRANCE 323

      • 14.4.6.1 Rising veterinary healthcare expenditure to drive market 323

    • 14.4.7 ITALY 330

      • 14.4.7.1 Growing livestock population and rising awareness to

    • 14.4.8 SPAIN 337

      • 14.4.8.1 Rising animal population to drive market growth 337

    • 14.4.9 NETHERLANDS 344

      • 14.4.9.1 Large pet population to fuel market growth 344

    • 14.4.10 REST OF EUROPE 351

  • 14.5 ASIA PACIFIC 358

    • 14.5.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 360

    • 14.5.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT

    • 14.5.3 ASIA PACIFIC: VOLUME ANALYSIS, BY MATERIAL

    • 14.5.4 CHINA 369

      • 14.5.4.1 China to dominate APAC market 369

    • 14.5.5 JAPAN 376

      • 14.5.5.1 Rising demand for imported breeds to drive market 376

    • 14.5.6 INDIA 383

      • 14.5.6.1 Rising livestock population and growing awareness to

    • 14.5.7 AUSTRALIA 391

      • 14.5.7.1 Rising livestock animal population and increasing

    • 14.5.8 SOUTH KOREA 398

      • 14.5.8.1 Increasing demand for preventive care and aging

    • 14.5.9 THAILAND 405

      • 14.5.9.1 Increasing companion animal population to boost market growth 405

    • 14.5.10 NEW ZEALAND 412

      • 14.5.10.1 Large pet population to increase demand for orthopedic products 412

    • 14.5.11 REST OF ASIA PACIFIC 419

  • 14.6 LATIN AMERICA 426

    • 14.6.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 427

    • 14.6.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT

    • 14.6.3 LATIN AMERICA: VOLUME ANALYSIS, BY MATERIAL

    • 14.6.4 BRAZIL 435

      • 14.6.4.1 Brazil to dominate LATAM market due to large companion animal population 435

    • 14.6.5 MEXICO 442

      • 14.6.5.1 Rising demand for animal-derived food products to contribute to market growth 442

    • 14.6.6 REST OF LATIN AMERICA 449

  • 14.7 MIDDLE EAST & AFRICA 456

    • 14.7.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 457

    • 14.7.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT

    • 14.7.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY MATERIAL

    • 14.7.4 GCC COUNTRIES 465

      • 14.7.4.1 Kingdom of Saudi Arabia (KSA) 472
        • 14.7.4.1.1 Technology advancements in veterinary orthopedics to boost growth 472
      • 14.7.4.2 United Arab Emirates (UAE) 479
        • 14.7.4.2.1 Government support and high livestock population to fuel UAE's market growth 479
      • 14.7.4.3 Rest of GCC Countries 486

    • 14.7.5 REST OF MIDDLE EAST & AFRICA 493

• 15 COMPETITIVE LANDSCAPE 501

  • 15.1 OVERVIEW 501

  • 15.2 KEY PLAYER STRATEGY/RIGHT TO WIN 501

  • 15.3 REVENUE ANALYSIS, 2021-2025 503

  • 15.4 MARKET SHARE ANALYSIS, 2025 504

    • 15.4.1 US MARKET SHARE ANALYSIS, 2025 506

    • 15.4.2 EUROPE MARKET SHARE ANALYSIS, 2025 507

    • 15.4.3 RANKING OF KEY MARKET PLAYERS 508

  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 510

    • 15.5.1 STARS 510

    • 15.5.2 EMERGING LEADERS 510

    • 15.5.3 PERVASIVE PLAYERS 510

    • 15.5.4 PARTICIPANTS 511

    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 512

      • 15.5.5.1 Company footprint 512
      • 15.5.5.2 Region footprint 513
      • 15.5.5.3 Product footprint 514
      • 15.5.5.4 Application footprint 515
      • 15.5.5.5 Animal type footprint 516

  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 517

    • 15.6.1 PROGRESSIVE COMPANIES 517

    • 15.6.2 RESPONSIVE COMPANIES 517

    • 15.6.3 DYNAMIC COMPANIES 517

    • 15.6.4 STARTING BLOCKS 517

    • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 519

      • 15.6.5.1 Detailed list of key startups/SMEs 519
      • 15.6.5.2 Competitive benchmarking of key startups 520

  • 15.7 BRAND/PRODUCT COMPARISON 521

  • 15.8 R&D EXPENDITURE OF KEY PLAYERS 522

  • 15.9 COMPANY VALUATION & FINANCIAL METRICS 522

    • 15.9.1 FINANCIAL METRICS 522

    • 15.9.2 COMPANY VALUATION 523

  • 15.10 COMPETITIVE SCENARIO 523

    • 15.10.1 PRODUCT LAUNCHES 523

    • 15.10.2 DEALS 524

    • 15.10.3 EXPANSIONS 525

    • 15.10.4 OTHER DEVELOPMENTS 526

• 16 COMPANY PROFILES 527

  • 16.1 KEY PLAYERS 527

    • 16.1.1 MOVORA 527

      • 16.1.1.1 Business overview 527
      • 16.1.1.2 Products offered 528
      • 16.1.1.3 Recent developments 533
        • 16.1.1.3.1 Deals 533
        • 16.1.1.3.2 Expansions 534
      • 16.1.1.4 MnM view 535
        • 16.1.1.4.1 Key strengths 535
        • 16.1.1.4.2 Strategic choices 535
        • 16.1.1.4.3 Weaknesses & competitive threats 535

    • 16.1.2 SECUROS SURGICAL (CENCORA, INC.) 537

      • 16.1.2.1 Business overview 537
      • 16.1.2.2 Recent developments 541
        • 16.1.2.2.1 Other developments 541
      • 16.1.2.3 MnM view 541
        • 16.1.2.3.1 Key strengths 541
        • 16.1.2.3.2 Strategic choices 542
        • 16.1.2.3.3 Weaknesses & competitive threats 542

    • 16.1.3 DEPUY SYNTHES (JOHNSON & JOHNSON) 543

      • 16.1.3.1 Business overview 543
      • 16.1.3.2 Products offered 544
      • 16.1.3.3 Recent developments 546
        • 16.1.3.3.1 Other developments 546
      • 16.1.3.4 MnM view 547
        • 16.1.3.4.1 Key strengths 547
        • 16.1.3.4.2 Strategic choices 547
        • 16.1.3.4.3 Weaknesses & competitive threats 547

    • 16.1.4 ARTHREX, INC 549

      • 16.1.4.1 Business overview 549
      • 16.1.4.2 Products offered 550
      • 16.1.4.3 Recent developments 553
        • 16.1.4.3.1 Product launches 553
        • 16.1.4.3.2 Other developments 553
      • 16.1.4.4 MnM view 553
        • 16.1.4.4.1 Key strengths 553
        • 16.1.4.4.2 Strategic choices 554
        • 16.1.4.4.3 Weaknesses & competitive threats 554

    • 16.1.5 ORTHOMED (UK) LTD 555

      • 16.1.5.1 Business overview 555
      • 16.1.5.2 Products offered 556
      • 16.1.5.3 Recent developments 558
        • 16.1.5.3.1 Product launches 558
        • 16.1.5.3.2 Deals 558
        • 16.1.5.3.3 Other developments 559
      • 16.1.5.4 MnM view 559
        • 16.1.5.4.1 Key strengths 559
        • 16.1.5.4.2 Strategic choices 560
        • 16.1.5.4.3 Weaknesses & competitive threats 560

    • 16.1.6 B. BRAUN SE 561

      • 16.1.6.1 Business overview 561
      • 16.1.6.2 Products offered 562

    • 16.1.7 VETERINARY INSTRUMENTATION 564

      • 16.1.7.1 Business overview 564
      • 16.1.7.2 Products offered 565

    • 16.1.8 ANTECH DIAGNOSTICS, INC 568

      • 16.1.8.1 Business overview 568
      • 16.1.8.2 Products offered 569
      • 16.1.8.3 Recent developments 570
        • 16.1.8.3.1 Deals 570

    • 16.1.9 RITA LEIBINGER GMBH & CO. KG 571

      • 16.1.9.1 Business overview 571
      • 16.1.9.2 Products offered 572
      • 16.1.9.3 Recent developments 574
        • 16.1.9.3.1 Deals 574

    • 16.1.10 BLUESAO 575

      • 16.1.10.1 Business overview 575
      • 16.1.10.2 Products offered 576

    • 16.1.11 INTEGRA LIFESCIENCES CORPORATION 578

      • 16.1.11.1 Business overview 578
      • 16.1.11.2 Products offered 579

    • 16.1.12 INTRAUMA S.P.A 580

      • 16.1.12.1 Business overview 580
      • 16.1.12.2 Products offered 581

    • 16.1.13 SURGICAL HOLDINGS VETERINARY 582

      • 16.1.13.1 Business overview 582
      • 16.1.13.2 Products offered 582
      • 16.1.13.3 Recent developments 583
        • 16.1.13.3.1 Deals 583

    • 16.1.14 PH ORTHCOM 584

      • 16.1.14.1 Business overview 584
      • 16.1.14.2 Products offered 585

    • 16.1.15 GERVETUSA 586

      • 16.1.15.1 Business overview 586
      • 16.1.15.2 Products offered 586

  • 16.2 OTHER PLAYERS 589

    • 16.2.1 NARANG MEDICAL LIMITED 589

    • 16.2.2 FUSION IMPLANTS 590

    • 16.2.3 BIO3DTECH 592

    • 16.2.4 ORTHOMAX MFG. CO. PVT. LTD 593

    • 16.2.5 VET ORTHOPEDICS 595

    • 16.2.6 WELL TRUST (TIANJIN) TECH CO., LTD 596

    • 16.2.7 VETERINARYIMPLANTS.COM (VETERINARY DIVISION OF GPC MEDICAL LTD.) 598

    • 16.2.8 INVICTOS 600

    • 16.2.9 SAFEX INC 601

    • 16.2.10 GSOURCE (ARCH MEDICAL SOLUTIONS) 602

• 17 RESEARCH METHODOLOGY 603

  • 17.1 RESEARCH DATA 603

  • 17.2 RESEARCH METHODOLOGY DESIGN 603

    • 17.2.1 SECONDARY DATA 604

      • 17.2.1.1 Key data from secondary sources 604

    • 17.2.2 PRIMARY DATA 605

      • 17.2.2.1 Key data from primary sources 606
      • 17.2.2.2 Key industry insights 607

  • 17.3 MARKET SIZE ESTIMATION 609

    • 17.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 609

    • 17.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 611

    • 17.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS 611

    • 17.3.4 TOP-DOWN APPROACH 612

    • 17.3.5 BOTTOM-UP APPROACH 613

  • 17.4 MARKET BREAKDOWN & DATA TRIANGULATION 616

  • 17.5 MARKET SHARE ESTIMATION 617

    • 17.5.1 RESEARCH ASSUMPTIONS 617

    • 17.5.2 GROWTH RATE ASSUMPTIONS 617

  • 17.6 RISK ASSESSMENT 618

  • 17.7 RESEARCH LIMITATIONS 618

    • 17.7.1 METHODOLOGY-RELATED LIMITATIONS 618

    • 17.7.2 SCOPE-RELATED LIMITATIONS 618

• 18 APPENDIX 619

  • 18.1 DISCUSSION GUIDE 619

  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 625

  • 18.3 CUSTOMIZATION OPTIONS 627

    • 18.3.1 PRODUCT ANALYSIS 627

    • 18.3.2 COMPANY INFORMATION 627

    • 18.3.3 GEOGRAPHIC ANALYSIS 627

    • 18.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 627

    • 18.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE 627

    • 18.3.6 MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS) 627

    • 18.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 627

  • 18.4 RELATED REPORTS 628

  • 18.5 AUTHOR DETAILS 629